Sort
17,288 grants matching “multiple sclerosis”
From therapeutic mechanisms to unraveling the pathophysiology of MS
$1,497,510Bibiana Bielekova · National Institute Of Neurological Disorders And Stroke · ZIA · FY2013 · NS
Mechanisms of molecular machines that regulate the neuronal cytoskeleton
$1,497,271Antonina Roll-Mecak · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
CTE and Posttraumatic Neurodegeneration: Neuropathology and Ex Vivo Imaging
$1,496,457Ann Carolyn McKee · Boston University Medical Campus · U01 · FY2016 · NS
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
$1,496,347Daniel Woo · University Of Cincinnati · U01 · FY2016 · NS
NINDS Quantitative MRI Core Facility
$1,496,165Govind Bhagavatheeshwaran · National Institute Of Neurological Disorders And Stroke · ZIC · FY2022 · NS
Dissecting Functional Autoimmunity through High-Resolution Multiomics in a Vitiligo Center of Research Translation (V-CoRT)
$1,495,911John E Harris · Univ Of Massachusetts Med Sch Worcester · P50 · FY2025 · AR
Center for Research Translation in Scleroderma
$1,494,942Frank C Arnett · University Of Texas Hlth Sci Ctr Houston · P50 · FY2006 · AR
Development of a SYF2 antisense oligonucleotide treatment for ALS and FTD
$1,492,509Samuel V Alworth · Acurastem, Inc. · R44 · FY2023 · AG
Detection of Prions
$1,491,280Byron Caughey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Engineered microglia for the treatment of Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)
$1,489,811Sunil Gandhi · Savanna Biotherapeutics, Inc. · R44 · FY2025 · NS
Development of Pathology-activated Drugs for Treatment of Neuropathic Pain
$1,485,925Peter M Grace · University Of Tx Md Anderson Can Ctr · UH3 · FY2024 · NS
Developing a PET tracer targeting myeloperoxidase activity for neurodegenerative diseases
$1,484,822John W Chen · Massachusetts General Hospital · RF1 · FY2022 · AG
Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways
$1,481,400Matthew D Disney · Scripps Florida · P01 · FY2017 · NS
Developmental Control Of Gene Expression In The Brain
$1,477,823Lynn D Hudson · Neurological Disorders And Stroke · Z01 · FY2007 · NS
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
$1,476,033Daniel Woo · University Of Cincinnati · U01 · FY2020 · NS
Targeting Remyelination to Treat Preterm Brain Injury
$1,476,000Bridget Lamonica Ostrem · University Of California, San Francisco · DP2 · FY2025 · NS
THERAPEUTIC REMYELINATION STRATEGIES IN A NOVEL MODEL OF MULTIPLE SCLEROSIS: JAPANESE MACAQUE ENCEPHALOMYELITIS
$1,476,000Oregon Health & Science University · · FY2009 · Department of the Army
Preclinical and Early Clinical Development of a Novel Drug for On-Demand Voiding
$1,473,895Edward Burgard · Dignify Therapeutics, Llc · U44 · FY2024 · NS
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
$1,469,200Daniel Woo · University Of Cincinnati · U01 · FY2019 · NS
Nuclear receptors: action, functions, and roles in disease
$1,461,795Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES
DEMYELINATING DISEASE: VIRAL AND IMMUNE FUNCTION
$1,461,289University Of Southern California · P01 · FY2003 · NS
Functions and Mechanisms of NF-kB Factors and their Regulators
$1,459,824Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Evaluation of clinical samples for virus detection for CNS disease
$1,458,521Eugene O. Major · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS
Implementing a coupled system of integrative ML modeling and data validation for elucidating microglial therapeutic targets in neurodegenerative disease
$1,457,344Karen Sachs · Modulo Bio, Inc. · R44 · FY2023 · MH
Pragmatic Trials in Maintenance Hemodialysis
$1,455,463Laura M Dember · University Of Pennsylvania · UH3 · FY2013 · DK